Showing 19,821 - 19,840 results of 66,360 for search '(( 2 d decrease ) OR ( 50 ((((ms decrease) OR (a decrease))) OR (nn decrease)) ))', query time: 1.44s Refine Results
  1. 19821

    Table 1_A novel super-resolution microscopy platform for cutaneous alpha-synuclein detection in Parkinson’s disease.docx by Ofir Sade (16624278)

    Published 2024
    “…On average, aSyn aggregate radii ranged between 40 and 200 nm and presented an average density of 0.001–0.1 molecules/nm<sup>2</sup>. Our dSTORM analysis thus highlights the potential of our platform for identifying quantitative characteristics of aSyn distribution in skin biopsies not previously described for PD patients while offering valuable insight into PD pathology by elucidating patient aSyn aggregation status.…”
  2. 19822

    Nomenclature by Fulin Wang (2250952)

    Published 2025
    “…The fluid production daily of the well b1-40-527 was 41.41 t/d and oil production was 1.53 t/d, water cut was 96.3% before the well releasing, then, the well was released firstly in July 2021, total effective thickness released is 6.6 m, after the released, the daily oil production was 1.92 t/d, the daily water cut was 96.3%, and oil production daily increased is 0.39 t/d, which is lower than the requirement of 0.79 t with oil price is 60 $/BBL and ROI is 1:2, therefore, the lower permeability layers were added, the total released thickness is to 10.7 m, which meets the requirement of unsealing, and the daily fluid production of the well b1-40-527 was to 67.79 t/d, the daily oil production was 3.2 t/d, the daily water cut was 95.3%, daily oil production increased was by 1.25 t/d, water cut decreased is 1.0%, and the releasing measure is valid still now.…”
  3. 19823

    VEGF-A siRNAs cause upregulation of phosphorylated Thr<sup>308</sup>-AKT and downregulation of Ang II and AT1R in NRK-52E cells in high glucose. by Xiaoyan Bai (554943)

    Published 2014
    “…(D) Increased pAKT (S473) and decreased Ang II and AT1R, while no effects on total AKT or pAKT (S473) mediated by VEGF-A_siRNA#1 and #2, as shown in Western blot analysis and (E) the relative quantification normalized by β-actin expression (*P<.05 vs. …”
  4. 19824
  5. 19825
  6. 19826

    Knockdown of Hes1 decreased MMP14 expression through the STAT3 pathway (A).... by MT Weng (835607)

    Published 2015
    “…<p>Knockdown of Hes1 decreased MMP14 expression through the STAT3 pathway (A). …”
  7. 19827
  8. 19828
  9. 19829

    Effect of 2% HQ, 0.05% INN and 0.1% TAC on hippocampal 5-HT level and 5-HT<sub>1A /1B</sub> receptor expression. by Huali Wu (349567)

    Published 2016
    “…<p>(A) Hippocampal 5-HT levels after 2% HQ, 0.05% INN and 0.1% TAC treatments. …”
  10. 19830

    Expression of GABAergic markers in the <i>Brd2+/−</i> mice and <i>Brd2+/+ littermate</i> controls. by Libor Velíšek (345515)

    Published 2013
    “…(D) Number of GAD67-immunopositive neurons in the CPu and GP was profoundly decreased in both parts of the striatum in <i>Brd2+/−</i> mice compared to <i>Brd2+/+</i> littermates illustrated further in microphotographs of upper outer quadrant of CPu in a <i>Brd2+/+</i> (E) and <i>Brd2+/−</i> mouse (F). …”
  11. 19831

    SIRT1 inhibition in dissociated E12.5 neocortical neurons enhanced SCPN/CSN subtype refinement, increasing the number of CTIP2-expressing, SATB2-negative neurons at the expense of... by Cameron Sadegh (11378606)

    Published 2021
    “…(D) Importantly, while the proportions of total CTIP2- and total SATB2-expressing neurons did not change relative to DMSO control following CHIC-35 SIRT1 inhibition, the relative proportion of CTIP2/SATB2 dual-expressing neurons decreased. …”
  12. 19832
  13. 19833
  14. 19834

    Ror2 expression predicts poor clinical outcome in patients with RCC. by Neal R. Rasmussen (679331)

    Published 2014
    “…Likewise, an analysis with all RCC bearing patients (M0+M1) (N = 468) showed a significant decrease in <b>C</b>) overall survival and <b>D</b>) cancer specific survival with Ror2-High compared Ror2-Low. …”
  15. 19835

    DataSheet2_LBX2-AS1 as a Novel Diagnostic Biomarker and Therapeutic Target Facilitates Multiple Myeloma Progression by Enhancing mRNA Stability of LBX2.ZIP by Haipeng Jia (423143)

    Published 2021
    “…Following treatment with cycloheximide or actinomycin D, LBX2 expression was examined in pcDNA3.1-LBX2-transfected MM cells at different time points. …”
  16. 19836
  17. 19837
  18. 19838
  19. 19839
  20. 19840

    The internal microstrain of CAP after solution exposure. by Mikayla M. Moynahan (10701958)

    Published 2021
    “…<p>Small variations in microstrain were shown in water, suggesting no major change in structure <b>(A)</b>. The microstrain decreased for PBS, MLC, and FC, although there are no trends relative to pH and wt% CO<sub>3</sub><sup>2-</sup> <b>(B-D)</b>. …”